Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Vital signs (diagnostic_test)
• Urine Pregnancy Test (diagnostic_test)
• Questionnaires (other)
• Blood Test (diagnostic_test)
• Duel-energy X-ray absorptiometry scan (diagnostic_test) — also listed as: DXA scan
• Multi-detector computed tomography (diagnostic_test) — also listed as: MDCT, CT scan
• Dual-energy X-ray absorptiometry scan (diagnostic_test) — also listed as: DXA scan

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• University of Iowa Hospitals and Clinics
  Iowa City, Iowa, United States
  Site recruitment: Not reported
• Columbia University Medical Center
  New York, New York, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Gonadotropins Subcutaneos (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Syneos Health
  Québec, Quebec, Canada
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Inclusion examinations (other)
• Aflibercept Injection [Eylea] (drug)
• SHAM injection (drug)
• Examinations during study (every month) (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• CHU dijon Bourgogne
  Dijon, France
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• 18F-FGLN PET Imaging (diagnostic_test)
• (18F)FPGLU (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Montefiore Hospital Clinical and Translational Research Center
  Pittsburgh, Pennsylvania, United States
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Blood samples collection for analysis (diagnostic_test) — also listed as: Uterine biopsy sample collection (only in biochemical pregnancy patients)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• IVI RMA Madrid
  Madrid, Madrid, Spain
  Site recruitment: Not reported
• IVI RMA Seville
  Seville, Seville, Spain
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Su2ura® GI system (device)
• Physical Examination (diagnostic_test)
• Vital Signs (diagnostic_test)
• Blood Test-Hematology (diagnostic_test)
• Blood Test-Biochemistry (diagnostic_test)
• Urine Pregnancy Test (diagnostic_test)
• Gastroscopy (diagnostic_test)
• Health-related quality of life (HR-QoL) (diagnostic_test)
• Visual Analogue Scale (VAS) (diagnostic_test)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Tel-Aviv Sourasky Medical Center, Ichilov
  Tel Aviv, Israel
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• MRI screening form (other)
• Urine pregnancy test (diagnostic_test)
• MR brain (diagnostic_test)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Mayo Clinic
  Rochester, Minnesota, United States
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Progesterone Vaginal Product (drug) — also listed as: Utrogestan
• Placebo (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• UMC Utrecht
  Utrecht, Netherlands
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• ICSI (procedure)
• IVF (procedure)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Beijing Obstetrics and Gynecology Hospital, Capital Medical University
  Beijing, Beijing Municipality, China
  Site recruitment: Not reported
• Huangshi Central Hospital
  Huangshi, Hubei, China
  Site recruitment: Not reported
• Renmin Hospital of Wuhan University
  Wuhan, Hubei, China
  Site recruitment: Not reported
• Xiangyang Central Hospital
  Xiangyang, Hubei, China
  Site recruitment: Not reported
• Second Affiliated Hospital, School of Medicine, Zhejiang University
  Hangzhou, Zhejiang, China
  Site recruitment: Not reported
• Jiaxing Maternity and Child Health Care Hospital
  Jiaxing, Zhejiang, China
  Site recruitment: Not reported
• Ningbo Women & Children's Hospital
  Ningbo, Zhejiang, China
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Avelumab administration at 10mg/kg (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Institut Bergonie
  Bordeaux, France
  Site recruitment: Not reported
• Centre Francois Baclesse
  Caen, France
  Site recruitment: Not reported
• Institut Paoli-Calmettes
  Marseille, France
  Site recruitment: Not reported
• Aphp Hopital Tenon
  Paris, France
  Site recruitment: Not reported
• Hospices Civils de Lyon - CHLS
  Pierre-Bénite, France
  Site recruitment: Not reported
• Institut Universitaire Du Cancer de Toulouse - Oncopole
  Toulouse, France
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• GnRH agonist (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Bravelle(follicle stimulating hormone) (drug)
• Saline ( placebo) (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• UCSF- Mission Bay
  San Francisco, California, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Follitropin delta (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Clinique Ovo
  Montreal, Quebec, Canada
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• HCG (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• CHU Arnaud de Villeneuve
  Montpellier, France
  Site recruitment: Not reported
• CHU Nimes
  Nîmes, France
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Aagaard Klinik
  Aarhus, Denmark
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Human Intravenous Immunoglobulins, (Privigen (R), CLS Behring) (drug) — also listed as: IVIg
• Prednisolone Tablets (drug)
• Human Albumin Solution (drug) — also listed as: Albumin infusion
• Placebo tablet (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• • The Centre for Recurrent Pregnancy Loss of Western Denmark, Department of Obstetrics and Gynaecology, Aalborg University Hospital
  Aalborg, Denmark
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Plerixafor (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Yale Fertility Center
  Orange, Connecticut, United States
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• OCP + Metformin (drug)
• OCP + Placebo (drug)
• Metformin + Placebo (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Penn State/ Hershey Medical Center
  Hershey, Pennsylvania, United States
  Site recruitment: Not reported
• University of Pennsylvania
  Philadelphia, Pennsylvania, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Letrozole-stimulated cycle strategy (procedure) — also listed as: LETS
• Artificial cycle strategy (procedure) — also listed as: AC

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• My Duc Hospital
  Ho Chi Minh City, Ho Chi Minh City, Vietnam
  Site recruitment: Recruiting
• My Duc Phu Nhuan Hospital
  Ho Chi Minh City, Ho Chi Minh City, Vietnam
  Site recruitment: Recruiting